{"schema_version":"secwatch.filing_event.v1","accession":"0001601485-24-000006","form_type":"8-K","ticker":"ELTX","cik":"0001601485","company_name":"Elicio Therapeutics, Inc.","filed_at":"2024-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.768243+00:00","generated_at":"2026-06-06T23:15:11.405337+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Elicio raises ~$4.9M from ATM equity sales since Q3 2023","bullets":["Issued and sold 584,170 shares under at-the-market program since September 30, 2023.","Net proceeds of approximately $4.89 million after deducting sales commissions.","Original ATM program authorized up to $21.0 million in aggregate offering price.","Program is ongoing with Stifel and Virtu Americas LLC as agents."],"urls":{"canonical":"https://secwatch.observer/filing/0001601485-24-000006","json":"https://secwatch.observer/filing/0001601485-24-000006.json","markdown":"https://secwatch.observer/filing/0001601485-24-000006.md","text":"https://secwatch.observer/filing/0001601485-24-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1601485/000160148524000006/0001601485-24-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1601485/000160148524000006/angn-20240116.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T23:15:11.405337+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}